Rituximab-Associated Progressive Multifocal Leukoencephalopathy: A Twenty-Year Update.

Bennett, Charles L; Witherspoon, Bartlett; Carson, Kenneth R

Bennett, Charles L; Witherspoon, Bartlett; Carson, Kenneth R.

Afiliação

Bennett CL; SONAR (Southern Network on Adverse Reactions) Program, University of South Carolina College of Pharmacy, Columbia, SC, 29208, USA.
Witherspoon B; SONAR (Southern Network on Adverse Reactions) Program, University of South Carolina College of Pharmacy, Columbia, SC, 29208, USA.
Carson KR; SONAR (Southern Network on Adverse Reactions) Program, University of South Carolina College of Pharmacy, Columbia, SC, 29208, USA. Kenneth_R_Carson@rush.edu.

Cancer Treat Res ; 184: 103-111, 2022.

Article em En | MEDLINE | ID: mdl-36449191

Assuntos

Leucoencefalopatia Multifocal Progressiva; Humanos; Leucoencefalopatia Multifocal Progressiva/induzido quimicamente; Rituximab/efeitos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucoencefalopatia Multifocal Progressiva Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Treat Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google